Tenax Therapeutics, Inc. (TENX) Financials

TENX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 121.7 million 8.1 million
March 31, 2026 123.2 million 8.5 million
Dec. 31, 2025 104.2 million 7.2 million
Sept. 30, 2025 102.8 million 6.6 million

TENX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.2 million 3.3 million
March 31, 2026 -9.3 million 2.8 million
Dec. 31, 2025 -13.4 million -14.4 million
Sept. 30, 2025 -9.2 million 5.6 million

TENX Net Income

No data available :(

TENX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 118.0 million - -
March 31, 2026 118.8 million - -
Dec. 31, 2025 97.6 million - -
Sept. 30, 2025 99.4 million - -

TENX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 50.9 million
March 31, 2026 45.2 million
Dec. 31, 2025 39.2 million
Sept. 30, 2025 39.7 million

TENX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 12.9 million 5.9 million -
March 31, 2026 - 11.5 million 5.0 million -
Dec. 31, 2025 - 10.5 million 5.9 million -
Sept. 30, 2025 - 10.3 million 6.5 million -

TENX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

TENX

Price: $1.58

52 week price:
1.31
19.40

Earnings Per Share: -1.41 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 57000

Ebitda: -44.8 million

Market Capitalization: 52.5 million

Links: